A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.
about
CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6.Prevalence of the CHEK2 R95* germline mutationKinView: a visual comparative sequence analysis tool for integrated kinome research.Genomic analysis reveals frequent TRAF7 mutations in intraneural perineuriomas.Study on the Mechanism of Cell Cycle Checkpoint Kinase 2 (CHEK2) Gene Dysfunction in Chemotherapeutic Drug Resistance of Triple Negative Breast Cancer Cells.
P2860
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A novel recurrent CHEK2 Y390C ...... increased breast cancer risk.
@en
A novel recurrent CHEK2 Y390C ...... increased breast cancer risk.
@nl
type
label
A novel recurrent CHEK2 Y390C ...... increased breast cancer risk.
@en
A novel recurrent CHEK2 Y390C ...... increased breast cancer risk.
@nl
prefLabel
A novel recurrent CHEK2 Y390C ...... increased breast cancer risk.
@en
A novel recurrent CHEK2 Y390C ...... increased breast cancer risk.
@nl
P2093
P2860
P356
P1433
P1476
A novel recurrent CHEK2 Y390C ...... increased breast cancer risk.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2014.443
P407
P50
P577
2015-01-26T00:00:00Z
P6179
1024440602